News by subject: HEALTH

Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce the completion of its observational...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024. Company Presentation...

100% reduction of target lesions in one melanoma and one pancreatic cancer patient observed among 4 Partial Responses (PR) to date which include 2 of 4 evaluable dose expansion patients and 2 of 2 MSI-H patients Durable stable disease (SD) in 3...

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips' subsidiaries Philips Holding USA and Philips Respironics have now reached final...

100% reduction of target lesions in one melanoma and one pancreatic cancer patient observed among 4 Partial Responses (PR) to date which include 2 of 4 evaluable dose expansion patients and 2 of 2 MSI-H patients Durable stable disease (SD) in 3...

Rakovina Therapeutics Inc. , ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce that...

Bright Peak Therapeutics, a biotechnology company developing multifunctional immunotherapies for cancer and autoimmune disease, today announced the presentation of new data characterizing the mechanisms of action, and potent preclinical antitumor...

Roth IAMS is proud to announce that it has been selected as the new vendor for the Ontario Ministry of Health's Facilities Condition Assessment (FCA), Application Support, Training and Data Transition Program. Under this contract, Roth IAMS will...

 MDNA113 is targeted to the tumor site where it is activated to simultaneously deliver two immunotherapies, an IL-2 superkine and anti-PD1 antibody, to the same cancer fighting immune cells in the tumor micro-environment (TME) to maximize efficacy...

ABC Fitness, the number one tech provider for fitness businesses everywhere, and Fitness World, a leading fitness organization committed to promoting health and wellness in western Canada, have partnered to elevate Fitness World's operational...

Knight Therapeutics Inc. ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton & Co....

Global ASICS study of 26,000 people reaffirms the connection between movement and the mind and uncovers a direct link between teenage physical activity and adult mental wellbeingEach additional year a teenager remains engaged in exercise is...

Novel camptothecin-peptide conjugates are well tolerated and associated with significant tumor regression in colorectal cancer and triple-negative breast cancer xenograft modelsSORT1 gene silencing results in drastic decrease in peptide-drug...

The Canadian Centre on Substance Use and Addiction (CCSA) proudly welcomes Scott Elliott to its Board of the Directors, following a Governor in Council appointment by the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate...

Savaria Corporation ("Savaria") a global leader in the accessibility industry, today announced it has acquired all the dumbwaiter and material lift assets of D.A. Matot, Inc. ("Matot"). Founded in 1888, Matot has functioned as a family-owned...

Medeloop, a trailblazer platform for clinical research launched in the United States and Canada, is proud to announce a groundbreaking milestone: the use of its innovative generative AI semantic graph platform to support the analysis of a clinical...

Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced five presentations including new data...

Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences", HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National...

Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBraintm Personal Brain Monitor, in 4 US states on Friday and sold 1.4% of its stock for more than $85 million, valuing the company at over $6 Billion in the...

IntelGenx Corp. (the "Company" or "IntelGenx") today announced that its co-developer, Chemo Research SL, through its agent and affiliate, Xiromed LLC ("Xiromed"), has received a Complete Response Letter ("CRL") from the U.S. Food and Drug...

In a release issued under the same headline on Thursday, April 4, 2024 by NeuroVigil, Inc., please note the contact information should be [email protected]. The corrected release follows: Silicon Valley-based Neurotechnology Powerhouse,...

Silicon Valley-based Neurotechnology Powerhouse, announced that it launched its non-invasive iBraintm Personal Brain Monitor, in 4 US states on Friday and sold 1.4% of its stock for more than $85 million on Saturday, valuing the company at over $6...

Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 23rd Annual Needham (Virtual) Healthcare Conference taking place April 8-11, 2024. Company Fireside Chat Presentation...

The Canadian Association for Suicide Prevention (CASP) is thrilled to announce the "Inspiring Hope Together" National Suicide Prevention Conference, scheduled to take place from May 29 to May 31, 2024, at the prestigious Pinnacle Hotel Harbourfront...

April 4, 2024  Mom & Baby Mobile Health Centers offering ultrasound screenings to expectant moms in Phoenix, Tucson, and Washington, DC Amsterdam, the Netherlands, and Arlington, VA ? Philips Foundation, with its mission to...

Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a...

Amid mounting pressures and unprecedented challenges across the globe, psychologically safe workplaces have become a necessity for building organizational resilience and sustainable success. Leaders at every level recognize that they need to...

BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, is pleased to announce the closing of $1.168 million of convertible...

Arch Biopartners Inc., ("Arch" or the "Company") , announced today that Anesthesia Clinical Trials Unit (ACTU), an academic research organization in the Department of Anesthesia and Pain Management at the University Health Network (UHN), has joined...

Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed...

Autism Speaks Canada marks an evolution in collaborating with and standing alongside the autistic community by launching Autism Speaks Canada's World Autism Month campaign. The campaign includes a pledge to #ActFearlessly for change and the launch of...

PsyCan, the not-for-profit trade association for the legal Canadian psychedelic medicine industry, welcomes the expansion of insurance coverage for psychedelic-assisted therapy (PaT) led by the Alberta Blue Cross. "We welcome Alberta Blue Cross as...

ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company") is proud to announce the official commercial launch of its first-in-class ?Follow-On' formula for infants ages...

Arch Biopartners Inc., ("Arch" or the "Company") , announced today that three additional clinical sites in Turkey have joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney...

Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an update on the Company's clinical study...

Achieve Life Sciences, Inc. , a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced fourth quarter and year-end 2023 financial...

Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2023...

Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of...

Nearly 30,000 deaths from noncommunicable diseases in Canada in 2019, were due to high body mass index (BMI), most related to diabetes, cardiovascular disease, and obesity-related cancers. There is extreme urgency for provincial and territorial...

Algernon Pharmaceuticals Inc. (the "Company" or "Algernon") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has closed on its agreement with Seyltx Inc. ("Seyltx"), a privately owned U.S. based drug...

With nearly 25 per cent of Canadians becoming seniors by 2030, and a global demographic shift towards an aging population, the need for innovative solutions to improve later life is critical. RTOERO, the trusted voice on healthy, active aging, is...

Markham Fertility Centre (MFC) and humm Canada proudly come together to announce better financing options for patients seeking fertility treatments. Time, cost, and distance can be barriers for patients when accessing fertility care. While the...

York University has long been a leader in health education and research, and we are excited to welcome the Ontario government's newest investment in the future of health care in York Region and beyond, announced today as part of the 2024 Budget:...

LifeLabs, a leading provider of laboratory diagnostic services, is thrilled to introduce our latest offering: At-Home Self-Collection Kits.    LifeLabs' At Home Kit Program provides a diverse range of self-collection kits for various health tests,...

Further to the announcement by Psyence Group Inc ("Psyence" or the "Company") of its plans for the strategic restructuring of its non-clinical business through a conditional M&A transaction (the "Transaction"), Psyence is pleased to announce that...

Yield10 Bioscience, Inc. ("Yield10" or the "Company"), an agricultural bioscience company, today reported that the Plant Biosafety Office ("PBO") of the Canadian Food Inspection Agency ("CFIA") recently reviewed information on the Company's E3902...

Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products across key therapeutic areas, announces that it has signed a...

Optimi Health Corp. (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, is thrilled to announce it has entered an international MDMA...

Top researchers in the field of type 1 diabetes (T1D) signed an open letter in support of renewed funding for the JDRF-CIHR Partnership to Defeat diabetes through Federal Budget 2024. The letter details the importance of funding research in the...

Hydreight Technologies Inc. ("Hydreight" or the "Company") a mobile clinical network and medical platform which enables flexible, at-home medical services across 50 states in the United States, is pleased to announce that it has partnered with...